Clinical Reasoning: A 28-year-old IV Drug User with Bilateral Basal Ganglia and Brainstem Lesions
Neurol 80:e73-e76, Lin, T.,et al, 2013
Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011
Clomipramine Induced Neuroleptic Malignant Syndrome and Pyrexia of Unknown Origin
BMJ 329:1333-1335, Haddow,A.M.,et al, 2004
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998
Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996
Neurotoxicity After Treatment with Muromonab-CD3
NEJM 323:487-488, Richards,J.M.,et al, 1990
Lithium Carbonate Intoxication, A Case Report and Review of the Literature
Arch Int Med 149:36-46, Simard,M.,et al, 1989
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Eosinophilia-Myalgia Syndrome-New Mexico
JAMA 262:3116, Belvins,W.L.,et al, 1989
Neuroleptic Malignant Syndrome
Arch Neurol 37:462-463, Morris,H.H.,et al, 1980
Anticholinergics
NEJM 288:1215, Greenblatt,D.J.,et al, 1973